James E. Fickenscher, Chief Financial Officer at Zynerba Pharmaceuticals, Inc. (ZYNE), sold 8,998 shares at $1.33 ($12K) on 2023-09-13, disclosed to the SEC on 2023-09-14.
Open-market sale of $12k ZYNE by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ZYNE | BUY | 2018-08-07 | $102K | — | Filing → |
| ZYNE | BUY | 2017-05-16 | $103K | — | Filing → |
| ZYNE | BUY | 2016-12-08 | $99K | — | Filing → |